The three largest U.S. drug distributors and a major generic-drug manufacturer have agreed to pay $260 million to settle the first federal trial over the companies’ role in fueling the U.S. opioid epidemic. Drug distributors McKesson Corp., Cardinal Health Inc. …
Source: Claims Journal